Cancer Treatment
Novel intrahepatic arterial chemotherapy introduced for hepatocellular carcinoma
Published in Blood Weekly, August 11th, 2005
According to recent research from Japan, "Advanced HCC with portal vein invasion and/or intrahepatic metastasis has an unfavorable prognosis even after radical hepatic resection. The aim of this study was to evaluate the effectiveness of a novel postoperative adjuvant chemotherapy given through the hepatic artery and based on biochemical modulation using cisplatin (CDDP) and 5-fluorouracil (5-FU)."
"Fifteen patients with advanced HCC with portal vein invasion into the main trunk and/or intrahepatic metastases...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-08-11)
More Articles from Blood Weekly
- Spinal Cord Injury
Neural SCs delivered to injured cervical spinal cord by intrathecal injection - Stem Cell Transplantation
Autologous mesenchymal stem cell transplantation improves recovery after stroke - Stem Cell Transplantation
CD34+ cell dose plays role in preventing late infections in pediatric SCT - Tissue Engineering
Autologous epidermal cells induce wound closure of neurotrophic ulcerations - Tissue Engineering
Viable autologous semilunar heart valve can be created from stem cells - Hemophilus ducreyi
H. ducreyi dsrA mutant killed by normal human serum initiated by IgM binding - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
